VeriMom¿Es palmitoyl tripeptide-56 seguro durante el embarazo?
No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
Pregnancy-safe products containing palmitoyl tripeptide-56
Related ingredients
Frequently asked questions
- ¿Es palmitoyl tripeptide-56 seguro durante el embarazo?
- No harmonised CLP reproductive classification (ECHA Annex VI) and no SCCS/CIR reproductive safety flags were identified for palmitoyl tripeptide-56. No peer‑reviewed reports of developmental/reproductive toxicity were found in the literature. Topical peptides of this class are large molecules with low systemic absorption, but palmitoylation increases lipophilicity so low but measurable dermal uptake is plausible (hence e=1). Sources: ECHA Annex VI (no harmonised classification), CIR (no safety concern noted for cosmetic peptides generally), PubMed (no reproductive/toxicity studies found).
- ¿Es palmitoyl tripeptide-56 seguro durante la lactancia?
- No evidence of reproductive or lactation-specific toxicity; no mechanistic data indicating transfer into breastmilk. Given low expected systemic exposure after topical use, systemic levels are likely minimal but not zero, so exposure is low/measurable. Sources: PubMed (no relevant studies), ECHA (no harmonised classification), PubChem/CosIng (ingredient identity/uses).
- ¿Es palmitoyl tripeptide-56 seguro para la piel del bebé?
- No infant‑specific toxicity or developmental effects reported. Per guidance, infant skin has higher per‑kg exposure and a less mature barrier; for an ingredient with low but measurable adult absorption (e=1), increase exposure score by +1 for babies (e=2). No data support increased hazard or specific mechanisms in infants. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient info).
- ¿Cómo puntúa VeriMom a palmitoyl tripeptide-56?
- VeriMom puntúa palmitoyl tripeptide-56 en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a palmitoyl tripeptide-56 en el embarazo?
- Consulta nuestra lista de alternativas seguras a palmitoyl tripeptide-56 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.